Paper7822142
A corneal epithelial inhibitor of stromal cell collagenase synthesis identified as TGF-beta 2.
Strissel KJ and 2 others. Invest Ophthalmol Vis Sci, 1995. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. A corneal epithelial inhibitor of stromal cell collagenase synthesis identified as TGF-beta 2. Papers, record 7822142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7822142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Collagenases | Major topic |
| Cornea | Major topic |
| Corneal Stroma | Major topic |
| Transforming Growth Factor beta | Major topic |
| Animals | |
| Base Sequence | |
| Cell Line | |
| Cells, Cultured | |
| Culture Media, Conditioned | |
| Enzyme Inhibitors | |
| Epithelium | |
| Interleukin 1 Receptor Antagonist Protein | |
| Molecular Sequence Data | |
| RNA, Messenger | |
| Rabbits | |
| Receptors, Interleukin-1 | |
| Sialoglycoproteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 EY08408 | NEI NIH HHS | United States | R01EY008408 | PubMed and NIH | NIH RePORTER |
| R01 EY09828 | NEI NIH HHS | United States | R01EY009828 | PubMed and NIH | NIH RePORTER |
| T32-AR07098 | NIAMS NIH HHS | United States | T32AR007098 | PubMed and NIH | NIH RePORTER |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42262027 | NEDD8 Promotes the Progression and Inflammation of Keratoconus by Increasing the Expression of YAP1. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42262027 | PubMed |
| 36877777 | Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders. | J Ocul Pharmacol Ther | 2023 | https://conductscience.org/library/papers/36877777 | PubMed |
| 35879352 | BMP3 inhibits TGFβ2-mediated myofibroblast differentiation during wound healing of the embryonic cornea. | NPJ Regen Med | 2022 | https://conductscience.org/library/papers/35879352 | PubMed |
| 33825855 | Interleukin-1 and Transforming Growth Factor Beta: Commonly Opposing, but Sometimes Supporting, Master Regulators of the Corneal Wound Healing Response to Injury. | Invest Ophthalmol Vis Sci | 2021 | https://conductscience.org/library/papers/33825855 | PubMed |
| 33263285 | TGFβ1 and TGFβ2 proteins in corneas with and without stromal fibrosis: Delayed regeneration of apical epithelial growth factor barrier and the epithelial basement membrane in corneas with stromal fibrosis. | Exp Eye Res | 2021 | https://conductscience.org/library/papers/33263285 | PubMed |
| 33171906 | Lycium barbarum Polysaccharide Suppresses Expression of Fibrotic Proteins in Primary Human Corneal Fibroblasts. | J Clin Med | 2020 | https://conductscience.org/library/papers/33171906 | PubMed |
| 22933838 | Murine corneal stroma cells inhibit LPS-induced dendritic cell maturation partially through TGF-β2 secretion in vitro. | Mol Vis | 2012 | https://conductscience.org/library/papers/22933838 | PubMed |
| 20642439 | Role of transforming growth factor Beta in corneal function, biology and pathology. | Curr Mol Med | 2010 | https://conductscience.org/library/papers/20642439 | PubMed |
| 19862334 | TGF-beta-induced interleukin-6 participates in transdifferentiation of human Tenon's fibroblasts to myofibroblasts. | Mol Vis | 2009 | https://conductscience.org/library/papers/19862334 | PubMed |
| 19626678 | Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells. | J Cell Physiol | 2009 | https://conductscience.org/library/papers/19626678 | PubMed |
| 17592243 | Microarray for genes associated with signal transduction in diabetic OLETF keratocytes. | Korean J Ophthalmol | 2007 | https://conductscience.org/library/papers/17592243 | PubMed |
| 15086386 | High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic background. | Clin Exp Immunol | 2004 | https://conductscience.org/library/papers/15086386 | PubMed |
| 10729297 | No strong association between alleles of tumour necrosis factor alpha and interleukin-1 receptor antagonist and corneal melting associated with systemic vasculitis. | Br J Ophthalmol | 2000 | https://conductscience.org/library/papers/10729297 | PubMed |
| 9457509 | The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes. | Graefes Arch Clin Exp Ophthalmol | 1998 | https://conductscience.org/library/papers/9457509 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7822142
GET https://conductscience.org/api/papers/v1/7822142/authors